What does Virax Biolabs Group Ltd. do?

Jun 22 2025 07:13 PM IST
share
Share Via
Virax Biolabs Group Ltd. is a micro-cap company in the finance industry with a market cap of USD 3.56 million, currently operating at a loss and offering no dividends. Key metrics include a negative return on equity of -73.37% and a price-to-book ratio of 0.41.
Overview:
Virax Biolabs Group Ltd. operates in the finance industry and is categorized as a micro-cap company.

Financial Snapshot:
Market cap: USD 3.56 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -999,999.00
Return on Equity: -73.37%
Price to Book: 0.41

Contact Details:
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Virax Biolabs Group Ltd. technically bullish or bearish?
Jun 25 2025 09:13 AM IST
share
Share Via
How big is Virax Biolabs Group Ltd.?
Jun 22 2025 06:23 PM IST
share
Share Via